Last updated: 12 August 2024 at 7:21pm EST

George Wingate Lloyd Net Worth




The estimated Net Worth of George W. Lloyd is at least $76.8 Миллион dollars as of 2 June 2023. Mr Lloyd owns over 192,221 units of Royalty Pharma plc stock worth over $833,400 and over the last 4 years he sold RPRX stock worth over $72,607,528. In addition, he makes $3,395,000 as Exec. VP of Investments & Gen. Counsel at Royalty Pharma plc.

Mr Lloyd RPRX stock SEC Form 4 insiders trading

Mr has made over 22 trades of the Royalty Pharma plc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 192,221 units of RPRX stock worth $6,477,848 on 2 June 2023.

The largest trade he's ever made was selling 252,500 units of Royalty Pharma plc stock on 4 June 2021 worth over $11,617,525. On average, Mr trades about 64,600 units every 40 days since 2020. As of 2 June 2023 he still owns at least 30,000 units of Royalty Pharma plc stock.

You can see the complete history of Mr Lloyd stock trades at the bottom of the page.





Mr. George Wingate Lloyd biography

George Wingate Lloyd is the Exec. VP of Investments & Gen. Counsel at Royalty Pharma plc.

What is the salary of Mr Lloyd?

As the Exec. VP of Investments & Gen. Counsel of Royalty Pharma plc, the total compensation of Mr Lloyd at Royalty Pharma plc is $3,395,000. There are 2 executives at Royalty Pharma plc getting paid more, with Pablo Gerardo Legorreta having the highest compensation of $55,674,558.



How old is Mr Lloyd?

Mr Lloyd is 62, he's been the Exec. VP of Investments & Gen. Counsel of Royalty Pharma plc since . There are no older and 3 younger executives at Royalty Pharma plc.

What's Mr Lloyd's mailing address?

George's mailing address filed with the SEC is C/O ROYALTY PHARMA PLC, 110 EAST 59TH STREET, NEW YORK, NY, 10022.

Insiders trading at Royalty Pharma plc

Over the last 4 years, insiders at Royalty Pharma plc have traded over $863,995,127 worth of Royalty Pharma plc stock and bought 5,330,350 units worth $152,553,456 . The most active insiders traders include David C Hodgson, William E Ford и Capital Partners Gp, L.L.C..... On average, Royalty Pharma plc executives and independent directors trade stock every 13 days with the average trade being worth of $7,420,205. The most recent stock trade was executed by Rory B Riggs on 2 January 2024, trading 470,000 units of RPRX stock currently worth $13,221,100.



What does Royalty Pharma plc do?

royalty pharma is the industry leader in acquiring revenue-producing intellectual property – principally royalty interests in marketed and late stage biopharmaceutical products with $13 billion in assets. since inception in 1996, royalty pharma and its predecessors have invested approximately $5.8 billion to assemble a leading portfolio of royalty interests in pharmaceutical and biopharmaceutical products. royalty pharma’s strategy has been to acquire royalty interests in leading pharmaceutical and biotechnology products and hold these interests as part of a portfolio, seeking to diversify its revenue base across product and therapeutic classes. royalty pharma captures many of the strong and predictable aspects of the pharmaceutical industy while limiting the typical risks of biopharmaceutical companies. royalty pharma currently owns a diversified portfolio of royalty interests in several high- quality blockbuster biopharmaceutical products, including abbott’s humira®, j&j/merck’s remi



What does Royalty Pharma plc's logo look like?

Royalty Pharma plc logo

Complete history of Mr Lloyd stock trades at Royalty Pharma plc

Дата
#
Компания
инсайдер
Транзакция
Транзакция
Акции Цена за акцию Общая стоимость Акции после Источник
2 Jun 2023 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 192,221 $33.70 $6,477,848
2 Jun 2023
30,000
28 Mar 2023 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 112,779 $37.06 $4,179,590
28 Mar 2023
212,221
23 Feb 2023 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 25,000 $37.27 $931,750
23 Feb 2023
325,000
21 Nov 2022 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 40,000 $43.14 $1,725,600
21 Nov 2022
350,000
10 Nov 2022 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 50,000 $43.85 $2,192,500
10 Nov 2022
355,000
9 Aug 2022 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 20,854 $43.92 $915,908
9 Aug 2022
201,114
28 Jul 2022 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 4,046 $43.97 $177,903
28 Jul 2022
221,968
25 Jul 2022 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 75,100 $43.25 $3,248,075
25 Jul 2022
226,014
26 May 2022 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 100,000 $40.29 $4,029,000
26 May 2022
430,000
23 May 2022 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 100,000 $40.27 $4,027,000
23 May 2022
530,000
16 Nov 2021 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 250,000 $42.39 $10,597,500
16 Nov 2021
630,000
26 Jul 2021 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 13,362 $39.78 $531,540
26 Jul 2021
780,000
12 Jul 2021 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 23,149 $42.01 $972,489
12 Jul 2021
788,449
6 Jul 2021 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 88,489 $42.19 $3,733,351
6 Jul 2021
806,530
10 Jun 2021 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 70,000 $46.49 $3,254,300
10 Jun 2021
240,000
4 Jun 2021 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 252,500 $46.01 $11,617,525
4 Jun 2021
250,000
2 Jun 2021 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 62,500 $42.12 $2,632,500
2 Jun 2021
1,050,000
14 Apr 2021 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 69,822 $42.13 $2,941,601
14 Apr 2021
200,000
12 Apr 2021 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 449 $42.32 $19,002
12 Apr 2021
255,898
22 Mar 2021 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 54,729 $46.32 $2,535,047
22 Mar 2021
256,258
2 Mar 2021 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Продажа 125,000 $46.94 $5,867,500
2 Mar 2021
300,000
15 Jun 2020 George W. Lloyd
Исполнительный вице-президент, Investments и CLO
Купить 14,200 $28.00 $397,600
15 Jun 2020
11,200


Royalty Pharma plc executives and stock owners

Royalty Pharma plc executives and other stock owners filed with the SEC include: